Bluebird Bio | BLUE - سرمایه گذاری در بازار



سرمایه گذاری در بازار تغییر دادن تاریخ
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amgen USD 176.25B 24.32B 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Biogen USD 25.82B 5.28B 2025-12
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Gilead Sciences USD 152.28B 14.55B 2025-12
Incyte USD 19.39B 2.83B 2025-12
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Novartis USD 265.66B 9.48B 2025-09
Pfizer USD 141.57B 6.48B 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Tectonic Therapeutic USD 294M 77M 2025-09
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vertex Pharmaceuticals USD 115.03B 14.61B 2025-12